| Jodi Elicia Granger, RN | |
|
19611 Sr 20 West, Blountstown, FL 32424 | |
| (850) 674-5645 | |
| (850) 674-5420 |
| Full Name | Jodi Elicia Granger |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 19611 Sr 20 West, Blountstown, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386686475 | NPI | - | NPPES |
| RN | Other | FL | RN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN9170397 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jodi Elicia Granger, RN 19611 Sr 20 West, Blountstown, FL 32424 Ph: (850) 674-5645 | Jodi Elicia Granger, RN 19611 Sr 20 West, Blountstown, FL 32424 Ph: (850) 674-5645 |
News Archive
DSM Biomedical, a global leader in biomedical materials, today announced the development of VitroStealth™, a breakthrough non-biofouling (NBF) coating technology. Specifically developed to combine state of the art non-biofouling properties with high durability and fast processing, VitroStealth™ coating is scratch resistant and reduces unwanted protein absorption and cellular adhesion on surfaces.
Researchers at the University of Pennsylvania School of Medicine have discovered stem cells in the esophagus of mice that were able to grow into tissue-like structures and when placed into immune-deficient mice were able to form parts of an esophagus lining.
Despite the potential of new vaccines to prevent TB, new research shows that the removal of one strain of TB can allow a previously suppressed strain to succeed. Consequently, a vaccination program could result in the proliferation of strains more likely to be, or become, drug resistant, and could even result in an increased prevalence of the disease.
University of New South Wales (UNSW) researchers have announced they are developing a new class of experimental drug that has the potential to treat a diverse range of health problems, from inflammation and cancer through to eye and heart disease.
Today, the EDCTP-funded GMZ2 consortium starts volunteer enrolment for the phase IIb clinical trial of the candidate malaria vaccine GMZ2 in Uganda. This is the third trial site to initiate volunteer recruitment for this multi-country study. Vaccination is already underway at trial sites in Gabon (November 2010) and Burkina Faso (April 2011). The Uganda site is in the peri-urban area of Iganga/Mayuge, at the Iganga Hospital. Akin to most areas in Uganda, malaria is one of the major health problems in this district. A team from Makerere University (Kampala) is conducting the trial.
› Verified 4 days ago
Laura Ford, ARNP Registered Nurse Medicare: May Accept Medicare Assignments Practice Location: 20370 Ne Burns Ave, Blountstown, FL 32424 Phone: 850-237-3000 Fax: 850-237-3001 | |
Linda Dasher, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 19611 State Road 20 W, Blountstown, FL 32424 Phone: 850-674-5645 Fax: 850-674-5420 | |
Vanessa Gammill Lickson, APRN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 16875 Ne Cayson St, Blountstown, FL 32424 Phone: 850-674-2244 Fax: 850-674-2249 | |
Brooke Revell Sansom, APRN Registered Nurse Medicare: Medicare Enrolled Practice Location: 19611 Fl-20 West, Blountstown, FL 32424 Phone: 850-674-5645 |